Verwendung von Daptomycin

Patent europeic · EP1674107 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1674107
Numer da la dumonda
EP06006697
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
24-09-1999
Publitgà
28-06-2006
Concedì
24-08-2016
Stritgà
23-09-2019
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 38/12 (2006.01)
A61P 31/04 (2006.01)
Prioritad
US 101828 P 25.09.1998
US 125750 P 24.03.1999
Derivà da
EP99949913
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-09-2019

    Durada maximala cuntanschida

    Published in Swissreg on 30.09.2019

  2. 15-12-2016

    Adressa midada

    Owner
    Cubist Pharmaceuticals LLC, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA → Cubist Pharmaceuticals LLC, Weystrasse 20, 6000 Luzern 6

    Published in Swissreg on 15.12.2016

  3. 03-11-2016

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 03.11.2016

  4. 24-08-2016

    Concedì

    Published in Swissreg on 24.08.2016

Partidas

Possessur

Cubist Pharmaceuticals LLC

Weystrasse 20, 6000 Luzern 6

Represchentant

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventur

Oleson, Frederick B. Jr.

Concord, MA01742, US

Tally, Francis P.

Lincoln, MA 01733, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.